FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280495521> ?p ?o ?g. }

• W4280495521 endingPage "1523" @default.
• W4280495521 startingPage "1512" @default.
• W4280495521 abstract "Conventional healthcare models struggle to engage those at risk of hepatitis C virus (HCV) infection. This international study evaluated point-of-care (PoC) HCV RNA diagnostic outreach and direct-acting antiviral (DAA) treatment for individuals receiving opioid agonist therapy (OAT) in community pharmacies.We assessed the effectiveness of a roving nurse-led pathway offering PoC HCV RNA testing to OAT clients in community pharmacies relative to conventional care.Pharmacies in Scotland, Wales, and Australia were randomised to provide PoC HCV RNA testing or conventional referral. Pharmacists directed OAT clients to on-site nurses (intervention) or local clinics (control). Infected participants were treated with DAAs, alongside OAT. Primary outcome was the number of participants with sustained virologic response at 12 weeks (SVR) and analysed using mixed effects logistic regression in the intention-to-treat (ITT) population.Forty pharmacies were randomised. The ITT population contained 1410 OAT clients. In the conventional arm (n = 648), 62 (10%) agreed to testing, 17 (27%) were tested, 6 (35%) were positive and 5 (83%) initiated treatment. In the intervention arm (n = 762), 148 (19%) agreed to testing, 144 (97%) were tested, 23 (16%) were positive and 22 (96%) initiated treatment. SVR was obtained by 2 (40%; conventional) and 18 (82%; intervention). Intervention arm participants had higher odds of testing, OR 16.95 (7.07-40.64, p < 0.001); treatment, OR 4.29 (1.43-12.92, p = 0.010); and SVR, OR 8.64 (1.82-40.91, p = 0.007).Nurse-led PoC diagnosis in pharmacies made HCV care more accessible for OAT clients relative to conventional care. However, strategies to improve testing uptake are required.NCT03935906." @default.
• W4280495521 created "2022-05-22" @default.
• W4280495521 creator A5000934181 @default.
• W4280495521 creator A5004579061 @default.
• W4280495521 creator A5009988205 @default.
• W4280495521 creator A5023605193 @default.
• W4280495521 creator A5025864043 @default.
• W4280495521 creator A5044673676 @default.
• W4280495521 creator A5045036684 @default.
• W4280495521 creator A5048050814 @default.
• W4280495521 creator A5054494206 @default.
• W4280495521 creator A5058364532 @default.
• W4280495521 creator A5059416898 @default.
• W4280495521 creator A5070581264 @default.
• W4280495521 creator A5077097833 @default.
• W4280495521 creator A5080105245 @default.
• W4280495521 date "2022-05-10" @default.
• W4280495521 modified "2023-10-01" @default.
• W4280495521 title "Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial" @default.
• W4280495521 cites W1980958334 @default.
• W4280495521 cites W1990166011 @default.
• W4280495521 cites W2047761134 @default.
• W4280495521 cites W2113515047 @default.
• W4280495521 cites W2142011497 @default.
• W4280495521 cites W2157731289 @default.
• W4280495521 cites W2292090508 @default.
• W4280495521 cites W2344591610 @default.
• W4280495521 cites W2600141067 @default.
• W4280495521 cites W2620924543 @default.
• W4280495521 cites W2716907322 @default.
• W4280495521 cites W2744191372 @default.
• W4280495521 cites W2762789262 @default.
• W4280495521 cites W2765348434 @default.
• W4280495521 cites W2778545039 @default.
• W4280495521 cites W2798156155 @default.
• W4280495521 cites W2803611658 @default.
• W4280495521 cites W2889967332 @default.
• W4280495521 cites W2897619872 @default.
• W4280495521 cites W2898222507 @default.
• W4280495521 cites W2904696570 @default.
• W4280495521 cites W2906035093 @default.
• W4280495521 cites W2910317080 @default.
• W4280495521 cites W2945149169 @default.
• W4280495521 cites W2969821228 @default.
• W4280495521 cites W2982648473 @default.
• W4280495521 cites W2993063979 @default.
• W4280495521 cites W3033193408 @default.
• W4280495521 cites W3081672254 @default.
• W4280495521 cites W3114691931 @default.
• W4280495521 cites W3132126495 @default.
• W4280495521 cites W3134741282 @default.
• W4280495521 cites W3161186341 @default.
• W4280495521 doi "https://doi.org/10.1111/apt.16953" @default.
• W4280495521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35538396" @default.
• W4280495521 hasPublicationYear "2022" @default.
• W4280495521 type Work @default.
• W4280495521 citedByCount "4" @default.
• W4280495521 countsByYear W42804955212023 @default.
• W4280495521 crossrefType "journal-article" @default.
• W4280495521 hasAuthorship W4280495521A5000934181 @default.
• W4280495521 hasAuthorship W4280495521A5004579061 @default.
• W4280495521 hasAuthorship W4280495521A5009988205 @default.
• W4280495521 hasAuthorship W4280495521A5023605193 @default.
• W4280495521 hasAuthorship W4280495521A5025864043 @default.
• W4280495521 hasAuthorship W4280495521A5044673676 @default.
• W4280495521 hasAuthorship W4280495521A5045036684 @default.
• W4280495521 hasAuthorship W4280495521A5048050814 @default.
• W4280495521 hasAuthorship W4280495521A5054494206 @default.
• W4280495521 hasAuthorship W4280495521A5058364532 @default.
• W4280495521 hasAuthorship W4280495521A5059416898 @default.
• W4280495521 hasAuthorship W4280495521A5070581264 @default.
• W4280495521 hasAuthorship W4280495521A5077097833 @default.
• W4280495521 hasAuthorship W4280495521A5080105245 @default.
• W4280495521 hasBestOaLocation W42804955212 @default.
• W4280495521 hasConcept C104863432 @default.
• W4280495521 hasConcept C126322002 @default.
• W4280495521 hasConcept C159047783 @default.
• W4280495521 hasConcept C168563851 @default.
• W4280495521 hasConcept C2522874641 @default.
• W4280495521 hasConcept C2776135927 @default.
• W4280495521 hasConcept C2776408679 @default.
• W4280495521 hasConcept C2776455275 @default.
• W4280495521 hasConcept C2908647359 @default.
• W4280495521 hasConcept C512399662 @default.
• W4280495521 hasConcept C71924100 @default.
• W4280495521 hasConcept C99454951 @default.
• W4280495521 hasConceptScore W4280495521C104863432 @default.
• W4280495521 hasConceptScore W4280495521C126322002 @default.
• W4280495521 hasConceptScore W4280495521C159047783 @default.
• W4280495521 hasConceptScore W4280495521C168563851 @default.
• W4280495521 hasConceptScore W4280495521C2522874641 @default.
• W4280495521 hasConceptScore W4280495521C2776135927 @default.
• W4280495521 hasConceptScore W4280495521C2776408679 @default.
• W4280495521 hasConceptScore W4280495521C2776455275 @default.
• W4280495521 hasConceptScore W4280495521C2908647359 @default.
• W4280495521 hasConceptScore W4280495521C512399662 @default.
• W4280495521 hasConceptScore W4280495521C71924100 @default.
• W4280495521 hasConceptScore W4280495521C99454951 @default.

• next